The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals. (Q40885079)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Mycobacterium tuberculosis

0 references

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Gebremedhin Gebremicael

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Debbie van Baarle

11

object named as

Debbie van Baarle

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Tsehaynesh Messele

8

object named as

Tsehaynesh Messele

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Tom H M Ottenhoff

10

object named as

Tom H M Ottenhoff

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1

object named as

Desta Kassa

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Yodit Alemayehu

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Leonie Ran

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Justin Fransen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Dawit Wolday

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Belete Tegbaru

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

30 September 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

96

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

131-140

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26631832%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Vaccines against tuberculosis: where are we and where do we need to go?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

New diagnostic tests for tuberculosis: bench, bedside, and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Diagnostic performance of multiplex cytokine and chemokine assay for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Biomarkers of disease activity, cure, and relapse in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Immunological biomarkers of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Into the eye of the cytokine storm

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Cell-mediated immune responses in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Depressed T‐Cell Interferon‐γ Responses in Pulmonary Tuberculosis: Analysis of Underlying Mechanisms and Modulation with Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Specific cytokine patterns of pulmonary tuberculosis in Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Impact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Immunological parameters to define infection progression and therapy response in a well-defined tuberculosis model in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Tuberculosis After Commencing Antiretroviral Therapy for HIV Infection Is Associated With Elevated CXCL9 and CXCL10 Responses to Mycobacterium tuberculosis Antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Circulating levels of interleukin-7 in antiretroviral-naïve and highly active antiretroviral therapy-treated HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Tuberculosis in Africa: learning from pathogenesis for biomarker identification

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.05.015

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40885079&oldid=2142988896"